Stereotactic radiation therapy for residual chemorefractory primary mediastinal non-seminomatous germ cell tumor after surgical thoracotomy

Pract Radiat Oncol. 2017 Jul-Aug;7(4):260-263. doi: 10.1016/j.prro.2017.01.004. Epub 2017 Jan 7.

Authors

Philippe Laflamme¹, Cédric Doucet¹, Christian Sirois², Neil Kopek³, Marie Vanhuyse⁴

Affiliations

¹ Department of Medicine, McGill University, Montreal, Canada.
² Division of Thoracic Surgery, McGill University Health Centre, Montreal, Canada.
³ Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada.
⁴ Department of Medicine, McGill University, Montreal, Canada; Department of Oncology, McGill University Health Centre, Montreal, Canada. Electronic address: marie.vanhuyse@mcgill.ca.

PMID: 28222996
DOI: 10.1016/j.prro.2017.01.004

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cisplatin / administration & dosage
Cisplatin / therapeutic use
Humans
Male
Mediastinal Neoplasms / drug therapy
Mediastinal Neoplasms / pathology
Mediastinal Neoplasms / radiotherapy*
Mediastinal Neoplasms / surgery*
Neoplasms, Germ Cell and Embryonal / drug therapy
Neoplasms, Germ Cell and Embryonal / pathology
Neoplasms, Germ Cell and Embryonal / radiotherapy*
Neoplasms, Germ Cell and Embryonal / surgery*
Radiosurgery / methods*
Radiotherapy Dosage
Testicular Neoplasms / drug therapy
Testicular Neoplasms / pathology
Testicular Neoplasms / radiotherapy*
Testicular Neoplasms / surgery*
Thoracotomy

Substances

Cisplatin

Supplementary concepts

Nonseminomatous germ cell tumor